54. J Cell Biol. 2018 Aug 6;217(8):2777-2798. doi: 10.1083/jcb.201703037. Epub 2018Jul 6.Fibronectin rescues estrogen receptor α from lysosomal degradation in breastcancer cells.Sampayo RG(1)(2)(3), Toscani AM(4), Rubashkin MG(5), Thi K(6), Masullo LA(7)(8), Violi IL(7), Lakins JN(5), Cáceres A(9), Hines WC(6), Coluccio Leskow F(4),Stefani FD(7)(8), Chialvo DR(10), Bissell MJ(6), Weaver VM(5), Simian M(11)(3).Author information: (1)Universidad de Buenos Aires, Instituto de Oncología "Ángel H. Roffo", ÁreaInvestigación, Buenos Aires, Argentina ro.sampayo@gmail.com.(2)Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales,Departamento de Fisiología y Biología Molecular y Celular, Ciudad Universitaria, Buenos Aires, Argentina.(3)Universidad Nacional de San Martín, Instituto de Nanosistemas, CampusMiguelete, San Martín, Argentina.(4)Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales,Departamento de Química Biológica, IQUIBICEN UBA-CONICET y Universidad Nacionalde Luján, Departamento de Ciencias Básicas, Buenos Aires, Argentina.(5)Center for Bioengineering and Tissue Regeneration, Department of Surgery,University of California, San Francisco, San Francisco, CA.(6)Division of Biological Systems and Engineering, Lawrence Berkeley NationalLaboratory, Berkeley, CA.(7)Centro de Investigaciones en Bionanociencias, Consejo Nacional deInvestigaciones Científicas y Técnicas, Buenos Aires, Argentina.(8)Departamento de Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.(9)Instituto de Investigación Médica Mercedes y Martín Ferreyra, Córdoba,Argentina.(10)Center for Complex Systems and Brain Sciences, Escuela de Ciencia yTecnología, Universidad Nacional de San Martín and Consejo Nacional deInvestigaciones Científicas y Tecnológicas, San Martín, Argentina.(11)Universidad de Buenos Aires, Instituto de Oncología "Ángel H. Roffo", ÁreaInvestigación, Buenos Aires, Argentina marsimian@gmail.com.Estrogen receptor α (ERα) is expressed in tissues as diverse as brains andmammary glands. In breast cancer, ERα is a key regulator of tumor progression.Therefore, understanding what activates ERα is critical for cancer treatment inparticular and cell biology in general. Using biochemical approaches andsuperresolution microscopy, we show that estrogen drives membrane ERα intoendosomes in breast cancer cells and that its fate is determined by the presence of fibronectin (FN) in the extracellular matrix; it is trafficked to lysosomes inthe absence of FN and avoids the lysosomal compartment in its presence. In thiscontext, FN prolongs ERα half-life and strengthens its transcriptional activity. We show that ERα is associated with β1-integrin at the membrane, and thisintegrin follows the same endocytosis and subcellular trafficking pathwaytriggered by estrogen. Moreover, ERα+ vesicles are present within human breasttissues, and colocalization with β1-integrin is detected primarily in tumors. Ourwork unravels a key, clinically relevant mechanism of microenvironmentalregulation of ERα signaling.© 2018 Sampayo et al.DOI: 10.1083/jcb.201703037 PMCID: PMC6080927 [Available on 2019-02-06]PMID: 29980625 